UCB Recognizes World Arthritis Day 2020
Today we are shining a light on World Arthritis Day in efforts to raise awareness of patients living with rheumatic and musculoskeletal diseases (RMDs), including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), as part of UCB’s ongoing commitment to the rheumatology community.
UCB has been proudly leading the way in connecting innovative science to unmet needs in specific patient populations, such as women of childbearing age and patients with axSpA and PsA. We are committed to providing a transformative experience for these patients.
As we lean into UCB’s Accelerate & Expand phase, it is our ambition to lead the way in providing holistic solutions that address patient needs at all key milestones in their healthcare journey.
Our innovative research in axSpA and PsA has laid a solid foundation to help us achieve our future vision for meeting the needs of these patients. There is great opportunity to innovate and improve care for patients with axSpA, starting with earlier and more accurate diagnoses.
Additionally, with the launch of the Advantage Hers campaign last month, we are continuing to highlight the unmet needs and unique challenges of women living with rheumatic diseases and other chronic inflammatory conditions with the help of our partner, tennis star and RA patient and campaign ambassador, Caroline Wozniacki.
Furthermore, we are empowering and equipping these patients to have informed conversations with their specialist about creating a management plan that is best tailored to their individual needs.
World Arthritis Day, led by the European League Against Rheumatism (EULAR), aims to help people living with RMDs avoid long-term complications by improving education of the condition, promoting early diagnosis and encouraging access to care.
EULAR’s campaign theme ‘Don’t Delay, Connect Today,’ calls on the public, physicians, policymakers and health professionals to connect and diagnose RMDs earlier and provide timely access to evidence-based treatment.
RMDs impact hundreds of millions of people worldwide and predominantly affect a person’s joints, muscles and connective tissues, causing pain and loss of physical function.
Today, and every day, UCB remains dedicated to providing innovative solutions to people living with these diseases and to raising public awareness of the importance of early diagnosis and available treatment options.